세계의 유방 재건 시장예측 2025년 : 제품별, 처치별, 종류별, 엔드유저별

■ 영문 제목 : Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025

MarketsandMarkets 회사가 출판한 조사자료로, 코드는 MD 7670 입니다.■ 상품코드 : MD 7670
■ 조사/발행회사 : MarketsandMarkets
■ 발행일 : 2020년 6월
■ 페이지수 : 137
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료기기
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD4,950 ⇒환산₩5,445,000견적의뢰/주문/질문
Five User (5명 열람용)USD6,650 ⇒환산₩7,315,000견적의뢰/주문/질문
Corporate License (동일 법인내 공유가능)USD8,150 ⇒환산₩8,965,000견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
본 조사보고서는 유방 재건의 세계 시장에 대해서 조사분석한 자료로서, 유방 재건의 세계 시장규모, 시장동향, 산업동향, 시장환경 분석, 세그멘트별 분석(제품별, 처치별, 종류별, 엔드유저별), 지역별 분석(미국, 유럽, 아시아등), 경쟁기업 정보등이 포함되어 있습니다.
■ 보고서 개요

“The global breast reconstruction market is projected to register a CAGR of 7.0% during the forecast period.”The global breast reconstruction market size is projected to reach USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0%. Growth in this industry is driven by the rising incidences of breast cancer, increasing awareness, and the availability of reimbursements. However, clinical risks and complications associated with breast reconstruction restrain the market growth.

“The acellular dermal matrix segment is anticipated to grow at the fastest growth rate during the forecast period.”
The breast reconstruction market, by product, is categorized into breast implants, tissue expanders, and acellular dermal matrix. The acellular dermal matrix segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the rising incidences of breast cancer, increasing number of mastectomies, and growing use usage of acellular dermal matrices.

“The immediate procedure segment is estimated to grow at a rapid rate during the forecast period.”
On the basis of procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. Immediate procedures are expected to remain the fastest-growing segment of the global breast reconstruction market during the breast reconstruction period. Factors such as the increasing number of surgeries post-mastectomy and rising awareness are driving the market.

“Asia Pacific is estimated to register the highest CAGR during the study period.”
Geographically, the breast reconstruction market is dominated by North America and Europe. However, the Asia Pacific market is estimated to grow at the fastest rate during the forecast period.

Breakdown of Profiles of Primary Participants:
• By Company Type: Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation: C-level: 30%, Director-level: 34%, and Others: 36%
• By Region: North America: 40%, Europe: 28%, Asia Pacific: 20%, and the Rest of the World: 12%

The key players in the breast reconstruction market include Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), Polytech Health & Aesthetics (Germany), Sientra (US), and .

Research Coverage:
The report analyzes the breast reconstruction market by product, procedure, type, end user, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use either or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the products of the top players in the breast reconstruction market
• Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of the leading players in the breast reconstruction market
• Market Development: Detailed information about emerging markets
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the breast reconstruction market

■ 보고서 목차

1 INTRODUCTION (Page No. – 17)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 20)
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 GROWTH FORECAST
2.4.3 TOP-DOWN APPROACH
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 27)

4 PREMIUM INSIGHTS (Page No. – 31)
4.1 BREAST RECONSTRUCTION: MARKET OVERVIEW
4.2 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2019
4.3 GEOGRAPHICAL SNAPSHOT OF THE BREAST RECONSTRUCTION MARKET

5 MARKET OVERVIEW (Page No. – 33)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of breast cancer
5.2.1.2 Increasing awareness
5.2.1.3 Reimbursements for breast reconstruction
5.2.2 RESTRAINTS
5.2.2.1 Clinical risks and complications of breast reconstruction procedures
5.2.2.2 Alternative non-surgical methods
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging markets
5.2.3.2 Development of 3D-printed implants
5.2.4 CHALLENGES
5.2.4.1 Product failures and recalls
5.3 PRICING ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM
5.5.1 COVID-19 IMPACT ON THE BREAST RECONSTRUCTION MARKET

6 BREAST RECONSTRUCTION MARKET, BY PRODUCT (Page No. – 39)
6.1 INTRODUCTION
6.2 BREAST IMPLANTS
6.2.1 BREAST IMPLANTS MARKET, BY TYPE
6.2.1.1 Silicone implants
6.2.1.1.1 Silicone breast implants to dominate the breast implants market during the forecast period
6.2.1.2 Saline implants
6.2.1.2.1 Low cost of implants to drive market growth
6.2.2 BREAST IMPLANTS MARKET, BY SHAPE
6.2.2.1 Round implants
6.2.2.1.1 Round implants show the highest end-user demand and market growth
6.2.2.2 Anatomical implants
6.2.2.2.1 Increasing implant-based breast reconstruction procedure will support the market growth
6.3 TISSUE EXPANDERS
6.3.1 RISING NUMBER OF BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH
6.4 ACELLULAR DERMAL MATRIX
6.4.1 RISING NUMBER OF ACELLULAR DERMAL MATRIX BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH

7 BREAST RECONSTRUCTION MARKET, BY PROCEDURE (Page No. – 46)
7.1 INTRODUCTION
7.2 IMMEDIATE PROCEDURES
7.2.1 IMMEDIATE PROCEDURES HOLD LARGEST MARKET SHARE
7.3 DELAYED PROCEDURES
7.3.1 RISING AWARENESS WILL SUPPORT MARKET GROWTH
7.4 REVISION PROCEDURES
7.4.1 DISSATISFACTION AND AESTHETIC ISSUES DRIVE DEMAND FOR REVISION

8 BREAST RECONSTRUCTION MARKET, BY TYPE (Page No. – 50)
8.1 INTRODUCTION
8.2 UNILATERAL BREAST RECONSTRUCTION
8.2.1 UNILATERAL RECONSTRUCTION DOMINATES THE MARKET, BY TYPE
8.3 BILATERAL
8.3.1 APAC TO SHOW HIGHEST GROWTH IN THE MARKET FOR BILATERAL BREAST RECONSTRUCTION

9 BREAST RECONSTRUCTION MARKET, BY END USER (Page No. – 53)
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 HOSPITALS TO DOMINATE THE BREAST RECONSTRUCTION MARKET DURING THE FORECAST PERIOD
9.3 COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS
9.3.1 GROWING PREFERENCE FOR OUTPATIENT TREATMENT AND PROCEDURES OVER HOSPITAL CARE DRIVES MARKET GROWTH
9.4 COVID-19 ANALYSIS

10 BREAST RECONSTRUCTION MARKET, BY REGION (Page No. – 56)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 The US dominates the North American breast reconstruction market
10.2.2 CANADA
10.2.2.1 Increasing incidence of breast cancer will drive market growth in Canada
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Germany dominates the European breast reconstruction market
10.3.2 FRANCE
10.3.2.1 Rising geriatric population will drive market growth
10.3.3 UK
10.3.3.1 Rising incidences of breast cancer will support market growth
10.3.4 ITALY
10.3.4.1 Rising geriatric population in Italy to drive the market
10.3.5 SPAIN
10.3.5.1 R&D investments for the development of innovative drugs form a key growth driver in the Spanish market
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 China accounts for the largest share of the APAC market
10.4.2 JAPAN
10.4.2.1 Growing geriatric population to drive the market in Japan
10.4.3 INDIA
10.4.3.1 Market growth in India is primarily driven by the rising incidence of breast cancer
10.4.4 REST OF ASIA PACIFIC
10.5 REST OF THE WORLD

11 COMPETITIVE LANDSCAPE (Page No. – 96)
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, 2019
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES AND APPROVALS
11.3.2 PARTNERSHIPS, COLLABORATIONS, MERGERS, AND AGREEMENTS
11.3.3 EXPANSIONS
11.3.4 ACQUISITIONS
11.3.5 OTHER DEVELOPMENTS
11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
11.4.1 VISIONARY LEADERS
11.4.2 INNOVATORS
11.4.3 DYNAMIC DIFFERENTIATORS
11.4.4 EMERGING COMPANIES

12 COMPANY PROFILES (Page No. – 103)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 JOHNSON & JOHNSON
12.2 ALLERGAN
12.3 SIENTRA
12.4 POLYTECH HEALTH & AESTHETICS
12.5 GC AESTHETICS
12.6 SEBBIN
12.7 IDEAL IMPLANT INCORPORATED
12.8 ESTABLISHMENT LABS S.A.
12.9 INTEGRA LIFESCIENCES
12.10 LABORATORIES ARION
12.11 SILIMED
12.12 GUANGZHOU WANHE PLASTIC MATERIALS
12.13 CEREPLAS
12.14 HANSBIOMED
12.15 RTI SURGICAL HOLDINGS
12.16 SHANGHAI KANGNING MEDICAL DEVICE
12.17 PMT CORPORATION

※본 조사보고서 [세계의 유방 재건 시장예측 2025년 : 제품별, 처치별, 종류별, 엔드유저별] (코드 : MD 7670) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 유방 재건 시장예측 2025년 : 제품별, 처치별, 종류별, 엔드유저별] 에 대해서 E메일 문의는 여기를 클릭하세요.